Walgreens Connected Care™ Multiple Sclerosis: Impact of Managed Therapy on Adherence to Medications Used to Treat Multiple Sclerosis and Related Comorbid Conditions
Summary
The ConnectedCare™ Multiple Sclerosis program significantly increased patient adherence to Multiple Sclerosis medications. Improved adherence was not negatively impacted by positive screenings for fatigue and depression.
DATE PUBLISHED
March 01, 2022
FORMAT
Publication
AUTHORS
Janeen DuChane, Bobby Clark, Francis Staskon, Rick Miller, Kathleen Love, Ian Duncan